Retraction

SETDB1 promotes glioblastoma growth via CSF-1-dependent macrophage recruitment by activating the AKT/mTOR signaling pathway

Citations (18)

18
Total Citations
10
Post-Retraction
(55.6%)
8
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
3 Within 30 days
6 Within 1 year
2 After 2+ years
988 Days since retraction (latest)
Retraction Note: BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors
Jianfeng Mu, Xuezeng Sun, Zhipeng Zhao et al. (5 authors)
Cell Death and Disease Open Access
Published: Jun 2025
988 days after retraction
Retraction Note: The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma
Zhongqiang Zhang, Xiao Tan, Jing Luo et al. (6 authors)
Cell Death and Disease Open Access
Published: Mar 2025
898 days after retraction
Epigenetic tuning of tumour-associated macrophages (TAMs): a potential approach in hepatocellular carcinoma (HCC) immunotherapy
Israa M Helal, Monica A. Kamal, Mostafa K Abd El-Aziz et al. (4 authors)
Expert Reviews in Molecular Medicine
Published: Jan 2024
3 citations
467 days after retraction
Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine
Fang Xie, Mei Huang, Xiansheng Lin et al. (8 authors)
Scientific Reports Open Access
Published: Nov 2023
433 days after retraction
Gene–Smoking Interaction Analysis for the Identification of Novel Asthma-Associated Genetic Factors
Jun-Ho Cha, Sungkyoung Choi
International Journal of Molecular Sciences Open Access
Published: Jul 2023
7 citations
313 days after retraction
CircPTK2/PABPC1/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancer
Xiangui Meng, Wen Xiao, Jiayin Sun et al. (8 authors)
Cancer Letters Open Access
Published: Nov 2022
86 citations
65 days after retraction
<scp>RNA</scp>‐binding protein <scp>DHX9</scp> promotes glioma growth and tumor‐associated macrophages infiltration via <scp>TCF12</scp>
Liang Liu, Xuelan Zhou, Shan Cheng et al. (15 authors)
CNS Neuroscience & Therapeutics Open Access
Published: Nov 2022
30 citations
55 days after retraction
Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape
Zide Wang, Hanlin Zhong, Xiaohong Liang et al. (4 authors)
Frontiers in Immunology Open Access
Published: Oct 2022
18 citations
22 days after retraction
C5aR1 promotes the progression of colorectal cancer by EMT and activating Wnt/β-catenin pathway
Duo Xu, Meirong Li, Longyan Ran et al. (6 authors)
Clinical & Translational Oncology Open Access
Published: Oct 2022
13 citations
12 days after retraction
Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma
Lizhi Pang, Fatima Khan, Amy B. Heimberger et al. (4 authors)
Trends in cancer Open Access
Published: May 2022
41 citations
120 days before retraction
Signal Pathways Involved in the Interaction Between Tumor-Associated Macrophages/TAMs and Glioblastoma Cells
Xiaojin Liu, Yuan Liu, Yiwei Qi et al. (8 authors)
Frontiers in Oncology Open Access
Published: May 2022
12 citations
140 days before retraction
Increased Expression of SETDB1 Predicts Poor Prognosis in Multiple Myeloma
Jing Xiang, Xiaotong Chen, Mengping Chen et al. (4 authors)
BioMed Research International Open Access
Published: Mar 2022
9 citations
182 days before retraction
METTL7B contributes to the malignant progression of glioblastoma by inhibiting EGR1 expression
Li Xu, Biao Peng, Haiqiang Wu et al. (6 authors)
Metabolic Brain Disease
Published: Mar 2022
6 citations
198 days before retraction
Macrophages/Microglia in the Glioblastoma Tumor Microenvironment
Jun Ma, Clark C. Chen, Ming Li
International Journal of Molecular Sciences Open Access
Published: May 2021
49 citations
481 days before retraction
Potential therapeutic targets in the tumor microenvironment of hepatocellular carcinoma: reversing the protumor effect of tumor-associated macrophages
Jingyi Zhou, Weiyu Wang, Qi Li
Journal of Experimental & Clinical Cancer Research Open Access
Published: Feb 2021
44 citations
581 days before retraction
SETDB1 in cancer: overexpression and its therapeutic implications.
Vanessa J Lazaro-Camp, Kiarash Salari, Xiangbing Meng et al. (4 authors)
PubMed
Published: Jan 2021
61 citations
628 days before retraction
Insight into the multi-faceted role of the SUV family of H3K9 methyltransferases in carcinogenesis and cancer progression
N. Saha, Andrew G. Muntean
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer Open Access
Published: Dec 2020
44 citations
634 days before retraction
Quick Stats
Total Citations: 18
Years Since Retraction: 3.2 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Apoptotic cell death: A possible key event in mediating the…
European Journal of Pharmacology • 42 citations
Role of cell cycle events and apoptosis in mediating the an…
European Journal of Pharmacology • 60 citations
Clinical significance of Serum Pepsinogen I/II and gastrin-…
European Journal of Inflammation • 1 citations
Loss of Cell Surface TFII-I Promotes Apoptosis in Prostate …
Journal of Cellular Biochemistry • 15 citations